Verition Fund Management LLC Has $688,000 Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Verition Fund Management LLC lessened its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 54.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,911 shares of the real estate investment trust’s stock after selling 20,492 shares during the quarter. Verition Fund Management LLC’s holdings in Omega Healthcare Investors were worth $688,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Daiwa Securities Group Inc. raised its position in Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Omega Healthcare Investors by 328.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after purchasing an additional 1,274,238 shares during the period. Marshall Wace LLP bought a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at approximately $20,962,000. FMR LLC raised its holdings in shares of Omega Healthcare Investors by 9.9% in the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after buying an additional 380,626 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after buying an additional 272,299 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.

Wall Street Analyst Weigh In

OHI has been the topic of a number of analyst reports. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. Scotiabank upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Truist Financial increased their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Royal Bank of Canada boosted their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. Finally, BMO Capital Markets raised Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target for the company in a report on Monday. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, Omega Healthcare Investors currently has an average rating of “Moderate Buy” and a consensus target price of $40.18.

Insider Transactions at Omega Healthcare Investors

In related news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Trading Up 0.0 %

Shares of Omega Healthcare Investors stock opened at $39.25 on Wednesday. The stock has a market capitalization of $10.60 billion, a P/E ratio of 28.86, a P/E/G ratio of 1.22 and a beta of 0.98. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The stock’s 50-day simple moving average is $40.45 and its 200 day simple moving average is $37.75. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.83%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.